Oncolytic virus treatment differentially affects the CD56 dim and CD56 bright NK cell subsets in vivo and regulates a spectrum of human NK cell activity

Wantoch, M, Wilson, EB, Droop, AP, Phillips, SL, Coffey, M, El‐Sherbiny, YM ORCID: https://orcid.org/0000-0003-4791-3475, Holmes, TD, Melcher, AA, Wetherill, LF and Cook, GP, 2022. Oncolytic virus treatment differentially affects the CD56 dim and CD56 bright NK cell subsets in vivo and regulates a spectrum of human NK cell activity. Immunology. ISSN 0019-2805

Full text not available from this repository.

Item Type:	Journal article
Publication Title:	Immunology
Creators:	Wantoch, M., Wilson, E.B., Droop, A.P., Phillips, S.L., Coffey, M., El‐Sherbiny, Y.M., Holmes, T.D., Melcher, A.A., Wetherill, L.F. and Cook, G.P.
Publisher:	Wiley
Date:	14 February 2022
ISSN:	0019-2805
Identifiers:	Number Type 10.1111/imm.13453 DOI 1520967 Other
Divisions:	Schools > School of Science and Technology
Record created by:	Linda Sullivan
Date Added:	24 Feb 2022 16:31
Last Modified:	24 Feb 2022 16:31
URI:	https://irep.ntu.ac.uk/id/eprint/45762

Actions (login required)

Edit View

Statistics

Views

Downloads